Literature DB >> 17081116

Unique neuronal functions of cathepsin L and cathepsin B in secretory vesicles: biosynthesis of peptides in neurotransmission and neurodegenerative disease.

Vivian Y H Hook1.   

Abstract

Proteases are required for the production of peptide neurotransmitters and toxic peptides in neurodegenerative diseases. Unique roles of the cysteine proteases cathepsin L and cathepsin B in secretory vesicles for the production of biologically active peptides have been demonstrated in recent studies. Secretory vesicle cathepsin L participates in the proteolytic conversion of proenkephalin into the active enkephalin, an opioid peptide neurotransmitter that mediates pain relief. Moreover, recent findings provide evidence that cathepsin B in regulated secretory vesicles participates in the production of toxic beta-amyloid peptides that are known to accumulate extracellularly in Alzheimer's disease brains. The neurobiological functions of cathepsins L and B demonstrate that these secretory vesicle cysteine proteases produce biologically active peptides. These results demonstrate newly identified roles for cathepsins L and B in neurosecretory vesicles in the production of biologically active peptides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081116     DOI: 10.1515/BC.2006.179

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Comparative analysis of neuropeptide cleavage sites in human, mouse, rat, and cattle.

Authors:  Allison N Tegge; Bruce R Southey; Jonathan V Sweedler; Sandra L Rodriguez-Zas
Journal:  Mamm Genome       Date:  2008-01-23       Impact factor: 2.957

2.  Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics.

Authors:  Jonathan H Wardman; Xin Zhang; Sandra Gagnon; Leandro M Castro; Xiaorong Zhu; Donald F Steiner; Robert Day; Lloyd D Fricker
Journal:  J Neurochem       Date:  2010-04-19       Impact factor: 5.372

3.  Endopin serpin protease inhibitors localize with neuropeptides in secretory vesicles and neuroendocrine tissues.

Authors:  Shin-Rong Hwang; Richard Bundey; Thomas Toneff; Vivian Hook
Journal:  Neuroendocrinology       Date:  2008-10-08       Impact factor: 4.914

4.  Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.

Authors:  Jingxin Qiu; Lingbao Ai; Cheppail Ramachandran; Bing Yao; Suhasni Gopalakrishnan; C Robert Fields; Amber L Delmas; Lisa M Dyer; Steven J Melnick; Anthony T Yachnis; Philip H Schwartz; Howard A Fine; Kevin D Brown; Keith D Robertson
Journal:  Lab Invest       Date:  2008-07-07       Impact factor: 5.662

5.  Autophagy in human type 2 diabetes pancreatic beta cells.

Authors:  M Masini; M Bugliani; R Lupi; S del Guerra; U Boggi; F Filipponi; L Marselli; P Masiello; P Marchetti
Journal:  Diabetologia       Date:  2009-04-15       Impact factor: 10.122

6.  Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling.

Authors:  Napoleão F Valadares; Márcia Dellamano; Andrea Soares-Costa; Flávio Henrique-Silva; Richard C Garratt
Journal:  BMC Struct Biol       Date:  2010-09-30

7.  A molten globule-to-ordered structure transition of Drosophila melanogaster crammer is required for its ability to inhibit cathepsin.

Authors:  Tien-Sheng Tseng; Chao-Sheng Cheng; Dian-Jiun Chen; Min-Fang Shih; Yu-Nan Liu; Shang-Te Danny Hsu; Ping-Chiang Lyu
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

8.  Activity-dependent dendritic spine shrinkage and growth involve downregulation of cofilin via distinct mechanisms.

Authors:  Barbara Calabrese; Jean-Michel Saffin; Shelley Halpain
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

9.  A python analytical pipeline to identify prohormone precursors and predict prohormone cleavage sites.

Authors:  Bruce R Southey; Jonathan V Sweedler; Sandra L Rodriguez-Zas
Journal:  Front Neuroinform       Date:  2008-12-16       Impact factor: 4.081

10.  Proteomic characterization of secretory granules in dopaminergic neurons indicates chromogranin/secretogranin-mediated protein processing impairment in Parkinson's disease.

Authors:  Gehua Wen; Hao Pang; Xu Wu; Enzhu Jiang; Xique Zhang; Xiaoni Zhan
Journal:  Aging (Albany NY)       Date:  2021-08-21       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.